Exchange: OTC·Updated 08:05 AM EDT

NWPHF Newron Pharmaceuticals Spa.

$20.00
$0.8874
(4.44%)
Pre-Market
Prev Close $20.00
EarningsMar 22
Mkt Cap$424.78M
Vol50.00

About NWPHF

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.
37

Bearish Sentiment

How do you feel about NWPHF?

flybyme
$NWPHF Now the waiting game, Beginning of Jan. 2027 end of tests phase 3 first one. Fda should lift ban soon. Price seems to have found its range.
1
flybyme
$NWPHF A bad day in the Office today. Thats life in these types of Shares. Everything else is still running around the world, only the FDA have put a Temp stop on the second trail. A total over reaction, lots of weak hands, small share holders losing there nuts.
1
flybyme
$NWPHF Tough times just now on really low volume. Until the boss Weber gives out some information , i think we could go under Chf 7.00. I might just take a few to sell for when the info to The FDA comes out. Not investment advice.

Advertisement|Remove ads.